Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Icon plc (ICLR)
NASDAQ:ICLR
ICLR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$181.51 - $347.72
Previous CloseN/A
Volume330.38K
Average Volume (3M)1.02M
Market Cap
$15.57B
Enterprise Value$26.86B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)21.3
Beta1.26
Next Earnings
Apr 23, 2025EPS Estimate
3.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.98
Shares Outstanding82,559,364
10 Day Avg. Volume1,099,442
30 Day Avg. Volume1,024,430
Standard Deviation0.10
R-Squared0.42
Alpha-0.00678
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.94
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.72
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.19
Enterprise Value/Ebitda15.81
Forecast
1Y Price Target
$256.50Price Target Upside27.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
---
Icon News
PremiumCompany Announcements
Icon Plc’s Earnings Call: Progress Meets Challenges
PremiumCompany Announcements
ICON plc Reports Steady Growth in 2024 Earnings
---
Bulls Say, Bears Say
Bulls Say
Share RepurchaseICON repurchased $400 million of stock in the quarter, bringing its total repurchases to $500 million for the year, and the company’s Board authorized a new share-repurchase program of up to $750 million, bringing its total current authorization to $1 billion.
Strategic PartnershipsICLR has signed 4 new large pharma partnerships since the merger, with the potential for significant revenue growth.
Bears Say
Cancellations ImpactICON saw elevated cancellations in the fourth quarter, which it expects to weigh on near-term sales and margins.
---
Ownership Overview
1.96% Insiders
27.32% Mutual Funds
43.37% Other Institutional Investors
26.17% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICLR FAQ
What was Icon plc’s price range in the past 12 months?
Icon plc lowest stock price was $181.51 and its highest was $347.72 in the past 12 months.
What is Icon plc’s market cap?
Icon plc’s market cap is $15.57B.
When is Icon plc’s upcoming earnings report date?
Icon plc’s upcoming earnings report date is Apr 23, 2025 which is in 60 days.
How were Icon plc’s earnings last quarter?
Icon plc released its earnings results on Feb 19, 2025. The company reported $3.43 earnings per share for the quarter, beating the consensus estimate of $3.428 by $0.002.
Is Icon plc overvalued?
According to Wall Street analysts Icon plc’s price is currently Undervalued.
Does Icon plc pay dividends?
Icon plc does not currently pay dividends.
What is Icon plc’s EPS estimate?
Icon plc’s EPS estimate is 3.34.
How many shares outstanding does Icon plc have?
Icon plc has 82,559,364 shares outstanding.
What happened to Icon plc’s price movement after its last earnings report?
Icon plc reported an EPS of $3.43 in its last earnings report, beating expectations of $3.428. Following the earnings report the stock price went up 5.499%.
Which hedge fund is a major shareholder of Icon plc?
Currently, no hedge funds are holding shares in ICLR
---
Icon Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$256.50 (27.08% Upside)
$256.50 (27.08% Upside)
Blogger Sentiment
Bullish
ICLR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 91.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 19.1%
Last 30 Days ▲ 19.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.79%
12-Months-Change
Fundamentals
Return on Equity
8.44%
Trailing 12-Months
Asset Growth
-0.66%
Trailing 12-Months
Company Description
Icon plc
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
---
ICLR Company Deck
---
ICLR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant progress in business development and cost management, yet faced challenges with revenue decline and elevated cancellations. The demand environment remains volatile, especially in the biotech sector, impacting overall growth expectations.Read More>---
ICLR Stock 12 Month Forecast
Average Price Target
$256.50
▲(27.08% Upside)
Technical Analysis
Best Analysts Covering ICLR
1 Year
1 Year Success Rate
20/31 ratings generated profit
1 Year Average Return
+4.57%
reiterated a buy rating 4 days ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 64.52% of your transactions generating a profit, with an average return of +4.57% per trade.
---